Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Uwagawa · SciRah

Researcher profile · Semantic Scholar

T. Uwagawa

Share profile

T. Uwagawa — researcher profile on SciRah

h-index: 24
Works: 137
Citations: 2,323

Most-cited papers

A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2
Shouhui Yang, Peijun He, Jian Wang, A. Schetter +15 more
2016Cancer Research291 citations Open access
Semantic Scholar
Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Yoshihiro Shirai, H. Shiba, K. Haruki, T. Horiuchi +5 more
2017Anticancer Research69 citations Open access
Semantic Scholar
The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy
Masashi Tsunematsu, K. Haruki, T. Taniai, Yoshiaki Tanji +9 more
2022Annals of Gastroenterological Surgery60 citations Open access
Semantic Scholar
Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis.
Kenei Furukawa, Masashi Tsunematsu, Yoshiaki Tanji, Shunta Ishizaki +6 more
2023Surgical oncology51 citations
Semantic Scholar
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
Y. Maruki, C. Morizane, Y. Arai, M. Ikeda +22 more
2020Journal of gastroenterology48 citations Open access
Semantic Scholar
Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.
N. Saito, Yoshihiro Shirai, T. Horiuchi, H. Sugano +4 more
2018Anticancer Research37 citations Open access
Semantic Scholar
Phase II Study of Gemcitabine in Combination With Regional Arterial Infusion of Nafamostat Mesilate for Advanced Pancreatic Cancer
T. Uwagawa, T. Misawa, Nobuhiro Tsutsui, Ryusuke Ito +4 more
2013American Journal of Clinical Oncology34 citations Open access
Semantic Scholar
Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.
Takeshi Gocho, T. Uwagawa, Kenei Furukawa, K. Haruki +5 more
2013Cancer Letters32 citations Open access
Semantic Scholar
Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin‐induced PAR1 and NF‐&kgr;B activation
Yoshihiro Shirai, T. Uwagawa, H. Shiba, Y. Shimada +5 more
2017Surgery28 citations
Semantic Scholar
Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy.
Kyohei Abe, T. Uwagawa, K. Haruki, Yuki Takano +4 more
2018Anticancer Research27 citations Open access
Semantic Scholar
Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer
T. Uwagawa, K. Yanaga
2015Surgery today (Print)24 citations
Semantic Scholar
Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
Ryota Iwase, K. Haruki, Y. Fujiwara, Kenei Furukawa +5 more
2013Journal of Surgical Research21 citations
Semantic Scholar
Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer
M. Matsumoto, S. Onda, Yosuke Igarashi, Ryoga Hamura +6 more
2023Surgery today (Print)20 citations
Semantic Scholar
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report
Eijiro Nagasaki, R. Kudo, M. Tamura, Kazumi Hayashi +8 more
2021Breast Cancer20 citations
Semantic Scholar
Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells
T. Taniai, Yoshihiro Shirai, Y. Shimada, Ryoga Hamura +12 more
2021Cancer Science20 citations Open access
Semantic Scholar
Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
Y. Fujiwara, H. Shiba, Ryota Iwase, K. Haruki +5 more
2013Journal of the American College of Surgeons20 citations
Semantic Scholar
Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
Yoshihiro Shirai, H. Shiba, Ryota Iwase, K. Haruki +5 more
2016Cancer Letters19 citations
Semantic Scholar
Hydroxyurea Decreases Gemcitabine Resistance in Pancreatic Carcinoma Cells With Highly Expressed Ribonucleotide Reductase
N. Funamizu, Y. Kamata, T. Misawa, T. Uwagawa +3 more
2012Pancreas18 citations
Semantic Scholar
Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
K. Haruki, H. Shiba, Y. Fujiwara, Kenei Furukawa +5 more
2012Digestive Diseases and Sciences17 citations Open access
Semantic Scholar
Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.
K. Haruki, H. Shiba, Y. Fujiwara, Kenei Furukawa +5 more
2013Surgery15 citations Open access
Semantic Scholar
Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells
H. Sugano, Yoshihiro Shirai, T. Horiuchi, N. Saito +5 more
2018Cancers13 citations Open access
Semantic Scholar
Prognostic significance of the hemoglobin, albumin, lymphocyte, platelet (HALP) score after hepatectomy for colorectal liver metastases
Kohei Okazaki, Kenei Furukawa, K. Haruki, S. Onda +8 more
2025Surgery today (Print)12 citations
Semantic Scholar
Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB
Yoshihiro Shirai, N. Saito, T. Uwagawa, H. Shiba +5 more
2018OncoTarget12 citations Open access
Semantic Scholar
Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
Norimitsu Okui, Y. Kamata, Yukiko Sagawa, Akiko Kuhara +4 more
2019Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]11 citations
Semantic Scholar
New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
T. Horiuchi, T. Uwagawa, Yoshihiro Shirai, N. Saito +5 more
2016Journal of Surgical Research10 citations
Semantic Scholar
Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model
Kenei Furukawa, T. Uwagawa, K. Haruki, Y. Fujiwara +5 more
2013Surgery today (Print)10 citations
Semantic Scholar
Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy.
Kenei Furukawa, T. Uwagawa, Ryota Iwase, K. Haruki +5 more
2012Anticancer Research10 citations
Semantic Scholar
Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer
T. Uwagawa, Taro Sakamoto, Kyohei Abe, Norimitsu Okui +5 more
2014Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Inhibition of lysosomal acid β-glucosidase and induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer.
Misturu Yanagaki, Yoshihiro Shirai, Y. Shimada, Ryoga Hamura +8 more
2022Carcinogenesis8 citations
Semantic Scholar
Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer.
Yoshihiro Shirai, S. Onda, Yoshiaki Tanji, Ryoga Hamura +11 more
2023Surgical oncology7 citations
Semantic Scholar
Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer
Masashi Tsunematsu, T. Uwagawa, S. Onda, Yoshihiro Shirai +6 more
2023Supportive Care in Cancer7 citations Open access
Semantic Scholar
Conversion surgery for undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: a case report
Yosuke Igarashi, Takeshi Gocho, T. Taniai, T. Uwagawa +6 more
2022Surgery Case Reports7 citations Open access
Semantic Scholar
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
T. Uwagawa, Taro Sakamoto, Takeshi Gocho, H. Shiba +7 more
2022PLoS ONE7 citations Open access
Semantic Scholar
Frequency and clinicopathological characteristics of biliary tract carcinomas harboring the FGFR2-fusion gene: A prospective observational study (PRELUDE study)
M. Ikeda, Y. Maruki, M. Ueno, T. Ioka +16 more
2019Annals of Oncology7 citations Open access
Semantic Scholar
The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancer
Ryoga Hamura, Yoshihiro Shirai, Masashi Tsunematsu, Yosuke Igarashi +9 more
2025Surgery today (Print)6 citations
Semantic Scholar
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
H. Shiozaki, Kenei Furukawa, K. Haruki, M. Matsumoto +9 more
2023Anticancer Research6 citations Open access
Semantic Scholar
Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial
Hiroto Kayashima, S. Itoh, M. Shimokawa, H. Hayashi +13 more
2023International Journal of Clinical Oncology6 citations Open access
Semantic Scholar
The effectiveness of adjuvant chemotherapy for Stage I pancreatic cancer based on the UICC 8th edition
Ryoga Hamura, K. Haruki, Y. Fujiwara, Masashi Tsunematsu +10 more
2022Langenbeck's archives of surgery (Print)6 citations
Semantic Scholar
Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case–control study
Kyohei Abe, T. Uwagawa, Ryoga Hamura, Yoshihiro Shirai +6 more
2022Medical Oncology6 citations Open access
Semantic Scholar
Gallbladder cancer accompanied by uncontrollable eosinophilia: report of a case
Masashi Tsunematsu, K. Haruki, T. Uwagawa, H. Shiba +1 more
2019International Cancer Conference Journal6 citations Open access
Semantic Scholar
Radical resection of a primary unresectable duodenal cancer after chemotherapy using S-1 and cisplatin: report of a case
Masaru Kanehira, Y. Futagawa, Kenei Furukawa, H. Shiba +2 more
2017Surgery Case Reports6 citations Open access
Semantic Scholar
Curative Resection After Gemcitabine, Cisplatin and S-1 Chemotherapy for Initially Unresectable Biliary Duct Cancer: A Case Report.
Kenei Furukawa, T. Uwagawa, Taro Sakamoto, H. Shiba +2 more
2015Anticancer Research6 citations
Semantic Scholar
Phase II Study of Adjuvant Chemotherapy With Gemcitabine and Nafamostat Mesilate for Pancreatic Cancer
T. Uwagawa, Taro Sakamoto, J. Yasuda, H. Shiozaki +5 more
2021Pancreas5 citations
Semantic Scholar
Effect of Chemoradiotherapy on Locoregional Recurrence After Pancreatectomy for Pancreatic Cancer
M. Matsumoto, Kenei Furukawa, T. Uwagawa, Yoshihiro Shirai +6 more
2024Anticancer Research4 citations
Semantic Scholar
Incidence and impact of food aversions among patients with cancer receiving outpatient chemotherapy: a one-year prospective survey
M. Suka, Atsushi Katsube, Reiko Fujimoto, T. Uwagawa +4 more
2024Supportive Care in Cancer4 citations Open access
Semantic Scholar
The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis
Ryoga Hamura, K. Haruki, T. Taniai, M. Yanagaki +8 more
2022International Journal of Clinical Oncology4 citations
Semantic Scholar
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Kazumi Hayashi, Eijiro Nagasaki, K. Nakada, M. Tamura +3 more
2017Journal of Infection and Chemotherapy4 citations
Semantic Scholar
Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma
T. Satake, C. Morizane, Hiroyuki Isayama, Akio Katanuma +13 more
2025Hepatology Research3 citations Open access
Semantic Scholar
Preoperative Therapy for Unresectable Locally Advanced Pancreatic Cancer for ≥6 Months Improves Prognosis After Pancreatectomy
M. Matsumoto, Yoshihiro Shirai, T. Uwagawa, Masashi Tsunematsu +9 more
2023Anticancer Research3 citations Open access
Semantic Scholar
Blood loss in laparoscopic distal pancreatectomy could be underestimated
Norimitsu Okui, Kenei Furukawa, T. Taniai, K. Haruki +6 more
2023Journal of hepato-biliary-pancreatic sciences3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Kenei Furukawa×30
Invite
Kenei Furukawa — researcher profile on SciRah
K. Haruki×28
Invite
K. Haruki — researcher profile on SciRah
K. Yanaga×26
Invite
K. Yanaga — researcher profile on SciRah
Yoshihiro Shirai×22
Invite
Yoshihiro Shirai — researcher profile on SciRah

×19

Invite

H. Shiba — researcher profile on SciRah

Toru Ikegami×18

Invite

Toru Ikegami — researcher profile on SciRah

Invite

S. Onda — researcher profile on SciRah

Takeshi Gocho×14

Invite

Takeshi Gocho — researcher profile on SciRah

Invite

T. Ohashi — researcher profile on SciRah

Ryoga Hamura×12

Invite

Ryoga Hamura — researcher profile on SciRah

Masashi Tsunematsu×11

Invite

Masashi Tsunematsu — researcher profile on SciRah

Y. Fujiwara×10

Invite

Y. Fujiwara — researcher profile on SciRah